Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

[Dynamic analysis of the pathological intestine and T cell activation from mesenteric lymph nodes in GVHD mouse].

Zhao K, Huang D, Zhao DM, Chen C, Wu QY, Pan B, Zeng LY, Li ZY, Yao Y, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2013 Sep;34(9):804-6. doi: 10.3760/cma.j.issn.0253-2727.2013.09.015. Chinese. No abstract available.

PMID:
24103882
2.

Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ.

Blood. 2008 Jan 15;111(2):954-62. Epub 2007 Oct 10.

3.

Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.

Hoffmann-Fezer G, Gall C, Zengerle U, Kranz B, Thierfelder S.

Blood. 1993 Jun 15;81(12):3440-8.

4.
5.

Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.

Noort WA, Benner R, Savelkoul HF.

Transplant Proc. 1995 Feb;27(1):384-6. No abstract available.

PMID:
7879030
6.

Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice.

Webster NL, Zufferey C, Pane JA, Coulson BS.

PLoS One. 2013;8(3):e59182. doi: 10.1371/journal.pone.0059182. Epub 2013 Mar 15.

8.
9.

Migration and activation of T cells during development of graft-versus-host disease in a mouse model.

Wen HS, Wang JM, Zhou H, Gong SI, Gao L, Wu Y.

Transplant Proc. 2013 Mar;45(2):713-8. doi: 10.1016/j.transproceed.2012.12.004.

PMID:
23498811
10.

Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.

Koenecke C, Prinz I, Bubke A, Schreder A, Lee CW, Pabst O, Förster R.

PLoS One. 2012;7(5):e38252. doi: 10.1371/journal.pone.0038252. Epub 2012 May 30.

11.

Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Rangarajan H, Yassai M, Subramanian H, Komorowski R, Whitaker M, Gorski J, Drobyski WR.

Blood. 2012 Jun 28;119(26):6354-64. doi: 10.1182/blood-2012-01-401596. Epub 2012 Apr 10.

12.

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

Choi SW, Hildebrandt GC, Olkiewicz KM, Hanauer DA, Chaudhary MN, Silva IA, Rogers CE, Deurloo DT, Fisher JM, Liu C, Adams D, Chensue SW, Cooke KR.

Blood. 2007 Nov 1;110(9):3447-55. Epub 2007 Jul 19.

13.

Maturation of cytotoxic effector cells at the site of allograft rejection.

Ascher NL, Chen S, Hoffman R, Simmons RL.

Transplant Proc. 1981 Mar;13(1 Pt 2):1105-7. No abstract available.

PMID:
6973856
14.

Effect of graft-versus-host disease on anti-tumor immunity.

Schreiber KL, Forman J.

J Immunol. 1990 Mar 1;144(5):2018-26.

PMID:
1968493
15.

Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.

Askenasy N, Mizrahi K, Ash S, Askenasy EM, Yaniv I, Stein J.

Biol Blood Marrow Transplant. 2013 Feb;19(2):185-95. doi: 10.1016/j.bbmt.2012.10.004. Epub 2012 Oct 16.

16.

Induction of unresponsiveness of antigen-specific T lymphocytes by oral administration of cedar pollen extract in mice.

Kohama Y, Tone H, Moriyama K, Arai S, Takae S, Tsujikawa K, Mimura T.

Biol Pharm Bull. 1995 Oct;18(10):1315-9.

PMID:
8593429
17.

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

Trenado A, Sudres M, Tang Q, Maury S, Charlotte F, Grégoire S, Bonyhadi M, Klatzmann D, Salomon BL, Cohen JL.

J Immunol. 2006 Jan 15;176(2):1266-73.

18.

Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.

Schultz KR, Paquet J, Bader S, HayGlass KT.

Bone Marrow Transplant. 1995 Aug;16(2):289-95.

PMID:
7581150
19.

Decreased expression of LFA-1 on peripheral blood lymphocytes in graft versus host disease.

Poritz LS, Tilberg AF, Koltun WA.

J Surg Res. 1997 May;69(2):316-20.

PMID:
9224399
20.

Supplemental Content

Support Center